Strongyloidiasis diagnosed by endoscopic biopsy in a patient with multiple myeloma

Community Oncology

Volumn 3, Issue 3, 2006, Pages 144-146

  Maguire, William F ^a   Mintzer, David M ^a   Stopyra, Gary A ^a   Stern, John ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; IVERMECTIN; THALIDOMIDE; TIABENDAZOLE; VINCRISTINE;

ABDOMINAL PAIN; AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DUODENUM BIOPSY; DYSPEPSIA; ENDOSCOPIC BIOPSY; HUMAN; MALE; MULTIPLE MYELOMA; NAUSEA; SHORT SURVEY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; VOMITING;

EID: 33645030864     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70671-4     Document Type: Short Survey

References (15)

1. Siddiqui AA, Berk AL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001;33:1040-1047.
2. Meyers WM, Connor DH, Neafie RC. Strongyloidiasis. In: Binford CH, Connor DH, eds. Pathology of Tropical and Extraordinary Diseases. Vol 2. Washington, DC: Armed Forces Institute of Pathology; 1976:428-432.
3. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004;7:208-217.
4. Genta RM. Dysregulation of strongyloidiasis: a new hypothesis. Clin Microbiol Rev 1992;5:345-355.
5. Safdar A, Malathum K, Rodriguez S, Husni R, Rolston KVI. Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 2004;100:1531-1536.
6. Choudhry U, Choudhry R, Romeo DP, Cammerer RC, Gopalswamy N. Strongyloidiasis: new endoscopic findings. Gastrointest Endosc 1995;42:170-173.
7. Kim J, Joo HS, Kim DH, Lim H, Kang YH, Kim MS. A case of gastric strongyloidiasis in a Korean patient. Korean J Parasitol 2003;41:63-67.
8. Overstreet K, Chen J, Rodriguez JW, Wiener G. Endoscopic and histopathologic findings of Strongyloides stercoralis infection in a patient with AIDS. Gastrointest Endosc 2003;58:928-931.
9. Thompson BF, Fry LC, Wells CD, et al. The spectrum of GI strongyloidiasis: an endoscopic-pathologic study. Gastrointest Endosc 2004;59:906-910.
10. Mansfield LS, Niamatali S, Bhopale V, et al. Strongyloides stercoralis: maintenance of exceedingly chronic infections. Am J Trop Med Hyg 1996;55:617-624.
11. Portugal R, Schaffel R, Almeida L, Spector N, Nucci M. Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study. Haematologica 2002;87:633-634.
12. Seet RCS, Gong LL, Tambyath PA. Image of the Month. Strongyloides stercoralis hyperinfection and syndrome of inappropriate secretion of antidiuretic hormone. Gastroenterology 2005;128:252.
13. Jaafar H, Kristensen J, Zwaan F, et al. Life-threatening gastrointestinal bleeding related to the treatment of strongyloidiasis hyperinfection in an immunocompromised patient. Orv Hetil 2004;145:181-185.
14. Shinozaki F, Takada K, Tamai T, Yasukawa M, Fujita S, Torii M. Strongyloidiasis associated with multiple myeloma in Ehime prefecture. Kansenshogaku Zasshi 1994;68:539-543.
15. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994;169:1076-1079.